Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Randomized controlled trials for multiple sclerosis: integrating pathology-driven outcomes to capture therapeutic efficacy — Massimo Filippi (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Randomized controlled trials for multiple sclerosis: integrating pathology-driven outcomes to capture therapeutic efficacy
Shared by
Massimo Filippi
Randomized controlled trials for multiple sclerosis: integrating pathology-driven outcomes to capture therapeutic efficacy
Letter
2025
en
Authors
Massimo Filippi
PP
Paolo Preziosa
MR
Maria A. Rocca
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2002
Design and quality considerations for randomized controlled trials in systemic sclerosis
Maria Kyriakidi
,
John P A Ioannidis
Article
2010
Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials
Ayşegül Yıldız
,
Eduard Vieta
,
Stefan Leucht
,
Ross J. Baldessarini
Article
2008
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis
Daniel R. Altmann
,
Bas Jasperse
,
Frederik Barkhof
,
K. Beckmann
,
Massimo Filippi
,
L. D. Kappos
,
P. D. Molyneux
,
Chris H. Polman
,
Carlo Pozzilli
,
Alan J. Thompson
,
K. Wagner
,
Tarek Yousry
,
D. H. Miller
Article
2001
Design and quality considerations for randomized controlled trials in systemic sclerosis: a systematic appraisal
Maria Kyriakidi
,
John P A Ioannidis
Article
2025
Evaluating Minimal Residual Disease Negativity as a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta‐Analysis of Randomized Controlled Trials
Ioannis Ntanasis‐Stathopoulos
,
Charalampos Filippatos
,
Anastasios Ntanasis‐Stathopoulos
,
Panagiotis Malandrakis
,
Efstathios Kastritis
,
Ourania Tsitsilonis
,
Meletios A Dimopoulos
,
Evangelos Terpos
,
Maria Gavriatopoulou
Discussion(0)
No comments yet. Be the first to comment.